<DOC>
	<DOCNO>NCT01245452</DOCNO>
	<brief_summary>To measure CRE work capacity index obtain submaximal testing ( W65 % /kg ) early RA patient treat tocilizumab compare Methotrexate alone . The secondary endpoint : analyze clinical efficacy Tocilizumab population correlate CRE response marker ( CRP , Hb , DAS , HAQ ) evaluate safety profile Tocilizumab .</brief_summary>
	<brief_title>Study Response Cardiorespiratory Endurance Early RA Patients Treated With Tocilizumab Methotrexate</brief_title>
	<detailed_description>Rheumatoid arthritis ( RA ) prevalent ( 1 % ) inflammatory rheumatic disorder . Interleukin-6 ( IL-6 ) emerge potential therapeutic target RA . This base great understanding role cytokine play various aspect pathogenesis RA . It show IL-6 responsible various clinical symptom , include , fatigue , anemia , anorexia , fever , well production autoantibody increase erythrocyte sedimentation rate , develop patient RA . Tocilizumab , monotherapy combination methotrexate , show effective RA patient insufficient response methotrexate disease-modifying antirheumatic drug . These observation effect tocilizumab extend patient refractory tumor necrosis factor inhibitor . Tocilizumab also slow progression structural joint damage . Furthermore , 5-year long-term safety efficacy show . The place Tocilizumab therapy early RA still unknown . Cardiorespiratory endurance ( CRE ) , fundamental component physical fitness severely impaired patient rheumatoid arthritis ( RA ) . It show intensive early treatment RA induce sustain clinical remission , improve general health physical fitness might therefore impact quality life RA patient . This study plan measure CRE work capacity index obtain submaximal testing ( W65 % /kg ) early RA patient treat tocilizumab compare Methotrexate alone .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Diagnosis RA ( accord American College Rheumatology ACR criterion ) Disease duration &lt; 2 year . Age 18 70 year old . Active RA define disease activity score 28 DAS28CRP score &gt; 3.2 swollen joint count â‰¥ 4 MTX naive Stable therapy corticosteroid nonsteroidal antiinflammatory drug NSAIDs Presence knee arthralgia synovitis ( addendum protocol synovial biopsy ) . Previous MTX treatment . Exclusion severe physical handicap perform CRE . Exclusion general safety ( history severe allergic reaction , sepsis , malignancy within 5 year , pregnancy , severe heart failure ) Concurrent treatment DMARDs MTX antiTNF biological therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Tocilizumab</keyword>
	<keyword>Cardiorespiratory endurance</keyword>
</DOC>